Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

Clinical trial NCT07486089 · RECRUITING

Trial details

NCT number: NCT07486089
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer (Locally Advanced or Metastatic)HER2-positive Breast Cancer Triple-Negative Breast Cancer (TNBC)

Start date: 2026-02-02
Primary completion: 2027-02-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.